title: Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer.
abstract: BACKGROUND
  Although a substantial proportion of patients undergoing neoadjuvant chemoradiation for invasive esophageal cancer develop a pathologic complete response (pCR), these patients nonetheless have a poor 5-year survival rate. We hypothesized that routine pathologic examination fails to identify some residual cancer.
  
  
  METHODS
  Patients undergoing esophagectomy for cancer at 2 tertiary care centers were identified. Archived tumor blocks were retrieved for patients with pCR, sectioned at 50-mum intervals and reexamined for residual cancer.
  
  
  RESULTS
  Seventy patients underwent neoadjuvant chemoradiation. Tumor blocks were available for 23 of 26 complete responders. A total of 159 blocks were reexamined. One patient was found to have a possible focus of residual invasive adenocarcinoma versus high-grade dysplasia. The remaining 22 patients had no residual disease.
  
  
  CONCLUSIONS
  A more aggressive examination protocol for postchemoradiation esophagectomy specimens may not result in significant upstaging. Inadequate pathologic examination is likely not a major factor in the suboptimal survival in patients with pCR.
authors: Department of Surgery, Oregon Health & Science University, Mail Code L223A, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.
authors: Eugene Y
authors: EY
authors: Chang
authors: Christina A
authors: CA
authors: Smith
authors: Christopher L
authors: CL
authors: Corless
authors: Charles R
authors: CR
authors: Thomas
authors: John G
authors: JG
authors: Hunter
authors: Blair A
authors: BA
authors: Jobe
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000401:mortality / Q000473:pathology* / Q000532:radiotherapy / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000401:mortality / Q000473:pathology* / Q000532:radiotherapy / Q000628:therapy*; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology* / Q000532:radiotherapy / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018365:Neoplasm, Residual; D015203:Reproducibility of Results; D015996:Survival Rate